E-therapeutics Plc Ord 0.1P is listed on the London Stock Exchange trading with ticker code ETX.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £713m, with approximately 269m shares in issue. Over the last year, E-therapeutics Plc share price has been traded in a range of 7.075, hitting a high of 8.50, and a low of 1.425.
E-therapeutics Plc, officially known as E-therapeutics Plc Ord 0.1P was formed in October of 2001, making the company eighteen years old. The company filed its latest accounts on 31st January 2015. E-therapeutics Plc currently has 6 directors, and has had 5 previous directors over the last 18 years. In the last set of accounts produced by Deloitte Llp, the company showed 2.98 million paid in salaries to the 26 staff (average wage of 115 thousand), with the directors receiving an average 215 thousand each. In the accounts filed in 2015, the company paid 0 in dividends. These accounts also showed E-therapeutics Plc to have a net worth of 36.39 million, with 33.82 million held in cash.
E-therapeutics Plc is in the Medicine and Biotech Research sector.
|Reneuron Group Plc (RENE.L)|
|Cello Group Plc (CLL.L)|
|Alliance Pharma Plc (APH.L)|
|Silence Therapeutics Plc (SLN.L)|
|Advanced Oncotherapy Plc (AVO.L)|
|Shares in Issue||269m|
|52 Week High||8.50|
|52 Week Low||1.425|